Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

West Pharmaceutical Services (WST) NYSE

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
3-Month Performance
View Chart

Fundamentals

See More
  • Market Capitalization, $K 6,284,310
  • Shares Outstanding, K 73,220
  • Annual Sales, $ 1,400 M
  • Annual Income, $ 96 M
  • 36-Month Beta 0.95
  • Price/Sales 4.23
  • Price/Book 5.50

Price Performance

See More
Period Period Low Period High Performance
1-Month
83.46 +0.28%
on 01/19/17
88.30 -5.22%
on 01/10/17
-1.32 (-1.55%)
since 12/19/16
3-Month
70.17 +19.27%
on 10/26/16
88.30 -5.22%
on 01/10/17
+10.96 (+15.08%)
since 10/19/16
52-Week
53.88 +55.34%
on 02/08/16
88.30 -5.22%
on 01/10/17
+26.67 (+46.76%)
since 01/19/16

Most Recent Stories

More News
Vial Adaptors for Reconstitution Drug Market to be Worth US$1.3 Billion by 2024: Reduced Risk of Needlestick Injuries Ups Demand, Notes TMR

ALBANY, New York, January 19, 2017 /PRNewswire/ --

Vial Adaptors for Reconstitution Drug Market to be Worth US$1.3 Billion by 2024: Reduced Risk of Needlestick Injuries Ups Demand, Notes TMR

The Global Vial Adaptor for Reconstitution Drug Market is fairly consolidated as top four players hold a leading share in the global market. A report by Transparency Market Research states that West Pharmaceutical...

Research Reports Coverage on Medical Supplies Stocks -- OraSure Technologies, Integra LifeSciences, Tandem Diabetes Care, and West Pharma

Stock-Callers.com shifts its attention to four Medical Instruments and Supplies equities, which are OraSure Technologies Inc. (NASDAQ: OSUR), Integra LifeSciences Holdings Corp. (NASDAQ: IART), Tandem...

West Receives Global Industry Recognitions for Innovative Contributions to Pharmaceutical Packaging and Drug Delivery

West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration and delivery, today announced it has received multiple honors for innovation in...

West Announces Quarterly Dividend and Share Repurchase Program

West Pharmaceutical Services, Inc. (NYSE: WST) today announced that the Company's Board of Directors has approved a first-quarter 2017 dividend of $0.13 per share. The dividend will be paid on February...

West Pharma (WST) Hits 52-Week High on Growth Prospects

Shares of West Pharmaceutical Services, Inc. (WST) reached a new 52-week high of $84.21 on Friday, Dec 9, 2016.

West Announces Expanded Contract Manufacturing Capabilities in Ireland

West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced the completion of a 60,000 square foot expansion at its contract...

SmarTrend Watching for Potential Pullback in Shares of West Pharmaceutical Services After 2.58% Gain

West Pharmaceutical Services (NYSE:WST) traded in a range yesterday that spanned from a low of $72.76 to a high of $75.72. Yesterday, the shares gained 2.6%, which took the trading range above the 3-day...

West Announces Third Quarter 2016 Results

West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the third quarter 2016, updated financial guidance for the full-year 2016, introduced sales growth outlook for full-year...

Dental Stocks' Earnings to Watch on Oct 27: MCK, WST, CNMD

Following are a few dental stocks that are gearing up to beat earnings this quarter.

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More

Business Summary

West Pharmaceutical Services applies technologies to the process of bringing new drug therapies and healthcare products. West's technologies include the design and manufacture of packaging components for pharmaceutical, healthcare and consumer products; research and development of drug delivery systems;...

See More

Support & Resistance

2nd Resistance Point 85.40
1st Resistance Point 84.88
Last Price 83.59
1st Support Level 83.74
2nd Support Level 83.12

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.